Clinical Diagnostics Companies, Innovation and Market Growth

Companies Latest Offerings in the Clinical Diagnostics Market with Forecast

Abbott

Description: A company specializes in core laboratory, molecular, point-of-care, rapid diagnostics, and transfusion medicine.

bioMérieux SA

Description: It mainly focuses on in vitro diagnostics in infectious diseases, cardiovascular emergencies, and cancer diagnostics.

QuidelOrtho Corporation

Description: This facilitates a complete portfolio of in vitro diagnostics, characterizing in immunoassay, molecular testing, clinical chemistry, and transfusion medicine.

Siemens Healthineers AG

Description: A firm explores solutions for immunoassays, chemistry, hematology, molecular, and urinalysis testing.

Bio-Rad Laboratories, Inc.

Description: Its offering includes a comprehensive portfolio of systems, software, and reagents for in-vitro diagnostics.

Qiagen

Description: A company’s portfolio offers diagnostics in oncology, infectious diseases, and immune monitoring.

Sysmex Corporation

Description: This firm specializes in in vitro diagnostics (IVD) and in the development and production of analyzers, reagents, and software for clinical laboratories.

Charles River Laboratories

Description: It usually provides bioanalytical services, biomarker testing, and specialized pathology for clinical trials (Phase I–III).

Quest Diagnostics Incorporated

Description: This provides over 3,500 tests for cancer, cardiovascular disease, infectious diseases, and neurological disorders.

Agilent Technologies, Inc.

Description: A company emphasizes a complete set of clinical diagnostics, including pathology, genomics, and companion diagnostics.

Clinical Diagnostics Market- Value Chain Analysis

R&D

• This prominently covers a systematic, multi-stage process, i.e. from discovery to regulatory approval and post-market monitoring, to develop novel tools for finding, monitoring, & treating diseases.
• Key Players: Roche Diagnostics, Abbott Laboratories, Danaher Corporation, etc.

Clinical Trials & Regulatory Approvals

• Clinical trials demonstrate validation of device performance, safety, and efficiency to secure regulatory approval from agencies, such as the CDSCO in India or the FDA in the US.
• Key Players: Azienda USL Reggio Emilia – IRCCS, Zhejiang Cancer Hospital, Harbinger Health, etc.

Patient Support & Services

• Firms are delivering home sample collection, digital report delivery, counseling, and logistical assistance for chronic or complex illnesses.
• Key Players: IQVIA, Quest Diagnostics, Healthy.io, etc.

Market Forecast

The global clinical diagnostics market size was estimated at USD 123.22 billion in 2025 and is predicted to increase from USD 131.4 billion in 2026 to approximately USD 234.36 billion by 2035, expanding at a CAGR of 6.64% from 2026 to 2035.

What are the Extensive Developments in the Clinical Diagnostics Market?

• In January 2026, Apollo Athenaa Women’s Cancer Centre unveiled MRI-guided Vacuum-Assisted Breast Biopsy (MRI-guided VABB). 
• In November 2025, Servier India joined with MedGenome and Strand Life Sciences to raise access to molecular testing for Acute Myeloid Leukaemia (AML) & Cholangiocarcinoma (CCA) across India.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com